Emerging drugs for alzheimer’s disease: Mechanisms of Action and Prospects for Cognitive Enhancing Medications

This publication has 95 references indexed in Scilit:

• Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Francais d'Etude de la Tetrahydroaminoacridine.
  BMJ, 1990
• GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug.
  Stroke, 1989
• Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects
  Drug Development Research, 1988
• Unproved Modality in the Treatment of Alzheimer‐Type Dementia
  Journal of the American Geriatrics Society, 1985
• Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in alzheimer's disease
  Neuroscience, 1985
• Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease
  Acta Neuropathologica, 1983
• Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia
  Neurology, 1982
• Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile Dementia
  The British Journal of Psychiatry, 1981
• Cholinomimetic Treatment Fails to Improve Memory Disorders
  New England Journal of Medicine, 1980
• NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
  Brain, 1976